International Network of VENous Thromboembolism Clinical Research Networks

COBRRA

Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism

Registration:

NCT03266783 

Sponsors:

CIHR (Canadian Institutes of Health Research)

Design

Open-label RCT (randomized clinical trial) comparing bleeding risk with rivaroxaban versus apixaban for acute treatment of VTE (venous thromboembolism)

Participating Sites

CanVECTOR logo

Lead Network:

CanVECTOR
Flag of Canada

Countries:

Australia & New Zealand, Canada

Lead Investigators

Dr. Lana Castellucci, MD, MSc

lcastellucci@toh.ca

Subscribe

* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.